Enrolling Clinical Trials
Our facility is continually active with various types of research activities. Below is a list of studies we are currently enrolling for:
Investigtional Drug Studies
|Ixekizumab Randomized, Open-Label Prefilled syringe vs. Auto injector
| Apremilast Randomized, Placebo-Controlled, Double-Blind, Double-Dummy
|Brodalumab vs. Placebo vs. Ustekinumab Randomized, placebo controlled- double blind study (Injection)
|Dupilumab/REGN668 Randomized, Double-Blind, Placebo-Controlled, Parrallel-Group, Dose-Ranging Study
|Adalimumab Double-blind placebo-controlled
HS lesions must be present in at least 2 distinct anatomic areas (Hurley Stage II or Hurley Stage III)
|Azaleic Acid Foam, 15% Randomized, Placebo Controlled (Topical) – applied twice daily for 12 weeks
|Registry Studies (Database only, no investigational medication)|
A prospective observational study of treatment patterns, effectiveness and safety outcomes in advanced basal cell carcinoma and basal cell carcinoma nevus syndrome patients
|Basal Cell Carcinoma|
If you would like to learn more about participation in one of these studies or future investigational studies please call our office at (206) 267-2100 and ask to speak with one of our research coordinators.
What are the different types of clinical trials?
Treatment trials test experimental treatments, new combinations of drugs or new approaches to surgery or radiation treatment.
Prevention trials look for better ways to prevent disease in people who never had the disease or to prevent a disease from returning. These approaches may include medications, vaccines, vitamins, minerals or lifestyle changes.
Diagnostic trials are conducted to find better tests or procedures for diagnosing a particular disease or condition.
Screening trials test the best way to detect certain diseases or health conditions.
Quality of Life trials (or Supportive Care trials) explore ways to improve comfort and the quality of life for individuals with a chronic illness.
What are the phases of clinical trials?
Clinical trials are conducted in phases. The trials at each phase have a different purpose and help scientists answer different questions.
In Phase I trials, researchers test an experimental drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase II trials, the experimental study drug or treatment is given to a larger group people (00-300) to see if it is effective and to further evaluate its safety.
In Phase III trials, the experimental study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the experimental drug or treatment to be used safely.
In Phase IV trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
Click here to learn about the benefits in participating in clinical trials from the National Psoriasis Foundation.